The Use of Cholinesterase Inhibitors Across All Stages of Alzheimer’s Disease
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Use of Cholinesterase Inhibitors Across All Stages of Alzheimer’s Disease
Authors
Keywords
Mini Mental State Examination, Memantine, Nursing Home Resident, Cholinesterase Inhibitor, Rivastigmine
Journal
DRUGS & AGING
Volume 32, Issue 7, Pages 537-547
Publisher
Springer Nature
Online
2015-06-01
DOI
10.1007/s40266-015-0273-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Responder analysis of a randomized comparison of the 13.3 mg/24 h and 9.5 mg/24 h rivastigmine patch
- (2015) José L Molinuevo et al. Alzheimers Research & Therapy
- 2014 Alzheimer's disease facts and figures
- (2014) Alzheimers & Dementia
- Effect of Vitamin E and Memantine on Functional Decline in Alzheimer Disease
- (2014) Maurice W. Dysken et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effectiveness of switching to the rivastigmine transdermal patch from oral cholinesterase inhibitors: a naturalistic prospective study in Alzheimer’s disease
- (2014) Annachiara Cagnin et al. NEUROLOGICAL SCIENCES
- Cognitive and Affective Changes in Mild to Moderate Alzheimer’s Disease Patients Undergoing Switch of Cholinesterase Inhibitors: A 6-Month Observational Study
- (2014) Gianfranco Spalletta et al. PLoS One
- Use of Medications of Questionable Benefit in Advanced Dementia
- (2014) Jennifer Tjia et al. JAMA Internal Medicine
- Effectiveness of Cholinesterase Inhibitors and Memantine for Treating Dementia: Evidence Review for a Clinical Practice Guideline
- (2013) Parminder Raina et al. ANNALS OF INTERNAL MEDICINE
- Current Pharmacologic Treatment of Dementia: A Clinical Practice Guideline from the American College of Physicians and the American Academy of Family Physicians
- (2013) Amir Qaseem ANNALS OF INTERNAL MEDICINE
- Pharmacodynamic, Pharmacokinetic and Pharmacogenetic Aspects of Drugs Used in the Treatment of Alzheimer’s Disease
- (2013) Muriel Noetzli et al. CLINICAL PHARMACOKINETICS
- The Safety, Tolerability, and Efficacy of Once-Daily Memantine (28 mg): A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial in Patients with Moderate-to-Severe Alzheimer’s Disease Taking Cholinesterase Inhibitors
- (2013) George T. Grossberg et al. CNS DRUGS
- High-Dose Donepezil (23 mg/day) for the Treatment of Moderate and Severe Alzheimer's Disease: Drug Profile and Clinical Guidelines
- (2013) Jeffrey L. Cummings et al. CNS Neuroscience & Therapeutics
- Transdermal Is Better than Oral: Observational Research of the Satisfaction of Caregivers of Patients with Alzheimers Disease Treated with Rivastigmine
- (2013) Mercè Boada et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- Assessment of factors that influence physician decision making regarding medication use in patients with dementia at the end of life
- (2013) Carole Parsons et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
- Alzheimer disease in the United States (2010-2050) estimated using the 2010 census
- (2013) L. E. Hebert et al. NEUROLOGY
- Memantine and Cholinesterase Inhibitors: Complementary Mechanisms in the Treatment of Alzheimer’s Disease
- (2013) Chris G. Parsons et al. NEUROTOXICITY RESEARCH
- Memantine in patients with Alzheimer's disease receiving donepezil: new analyses of efficacy and safety for combination therapy
- (2013) Alireza Atri et al. Alzheimers Research & Therapy
- Evaluating the cognitive effects of donepezil 23 mg/d in moderate and severe Alzheimer’s disease: analysis of effects of baseline features on treatment response
- (2013) Marwan Sabbagh et al. BMC Geriatrics
- Benefits of combined cholinesterase inhibitor and memantine treatment in moderate–severe Alzheimer's disease
- (2012) Serge Gauthier et al. Alzheimers & Dementia
- Effectiveness of antidementia drugs in delaying Alzheimer's disease progression
- (2012) Susan D. Rountree et al. Alzheimers & Dementia
- Subgroup Analysis of US and Non-US Patients in a Global Study of High-Dose Donepezil (23 mg) in Moderate and Severe Alzheimer’s Disease
- (2012) Stephen Salloway et al. American Journal of Alzheimers Disease and Other Dementias
- Randomized, Double-Blind, Parallel-Group, 48-Week Study for Efficacy and Safety of a Higher-Dose Rivastigmine Patch (15 vs. 10 cm2) in Alzheimers Disease
- (2012) Jeffrey Cummings et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- Validity, Significance, Strengths, Limitations, and Evidentiary Value of Real-World Clinical Data for Combination Therapy in Alzheimers Disease: Comparison of Efficacy and Effectiveness Studies
- (2012) Alireza Atri et al. Neurodegenerative Diseases
- Donepezil and Memantine for Moderate-to-Severe Alzheimer's Disease
- (2012) Robert Howard et al. NEW ENGLAND JOURNAL OF MEDICINE
- Memantine and cholinesterase inhibitor combination therapy for Alzheimer's disease: a systematic review
- (2012) Lucy E Farrimond et al. BMJ Open
- Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Reisa A. Sperling et al. Alzheimers & Dementia
- Tolerability and efficacy of memantine add-on therapy to rivastigmine transdermal patches in mild to moderate Alzheimer's disease: a multicenter, randomized, open-label, parallel-group study
- (2011) Seong Hye Choi et al. CURRENT MEDICAL RESEARCH AND OPINION
- Current and Emerging Drug Treatment Options for Alzheimerʼs Disease
- (2011) Nathan Herrmann et al. DRUGS
- Combination Therapy for Alzheimerʼs Disease
- (2011) Laxeshkumar Patel et al. DRUGS & AGING
- A 24-week, multicentre, open evaluation of the clinical effectiveness of the rivastigmine patch in patients with probable Alzheimer’s disease
- (2011) K. Articus et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Efficacy and Safety of Switching from Oral Cholinesterase Inhibitors to the Rivastigmine Transdermal Patch in Patients with Probable Alzheimer's Disease
- (2011) Hyun Jeong Han et al. Journal of Clinical Neurology
- Cholinesterase Inhibitor and Memantine Use in Newly Admitted Nursing Home Residents with Dementia
- (2011) Carole Parsons et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Dementia Medications and Risk of Falls, Syncope, and Related Adverse Events: Meta-Analysis of Randomized Controlled Trials
- (2011) Dae Hyun Kim et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Long-term Outcome and Prediction Models of Activities of Daily Living in Alzheimer Disease With Cholinesterase Inhibitor Treatment
- (2010) Carina Wattmo et al. ALZHEIMER DISEASE & ASSOCIATED DISORDERS
- Effectiveness and tolerability of high-dose (23 mg/d) versus standard-dose (10 mg/d) donepezil in moderate to severe Alzheimer's disease: A 24-week, randomized, double-blind study
- (2010) Martin R. Farlow et al. CLINICAL THERAPEUTICS
- The ACTION study: methodology of a trial to evaluate safety and efficacy of a higher dose rivastigmine transdermal patch in severe Alzheimer's disease
- (2010) Martin R. Farlow et al. CURRENT MEDICAL RESEARCH AND OPINION
- Effects of Rivastigmine Transdermal Patch and Capsule on Aspects of Clinical Global Impression of Change in Alzheimer’s Disease: A Retrospective Analysis
- (2010) Jeffrey L. Cummings et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- Withholding, Discontinuing and Withdrawing Medications in Dementia Patients at the End of Life
- (2010) Carole Parsons et al. DRUGS & AGING
- Memantine ER, a once-daily formulation for the treatment of Alzheimer's disease
- (2010) Nazem Bassil et al. EXPERT OPINION ON PHARMACOTHERAPY
- Efficacy of rivastigmine transdermal patch on activities of daily living: item responder analyses
- (2010) Gustavo Alva et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
- Switching cholinesterase inhibitors in older adults with dementia
- (2010) Fadi Massoud et al. INTERNATIONAL PSYCHOGERIATRICS
- Effect of discontinuing cholinesterase inhibitor therapy on behavioral and mood symptoms in nursing home patients with dementia
- (2009) Lori A. Daiello et al. American Journal Geriatric Pharmacotherapy
- Syncope and Its Consequences in Patients With Dementia Receiving Cholinesterase Inhibitors
- (2009) Sudeep S. Gill et al. ARCHIVES OF INTERNAL MEDICINE
- Long-term effects of the concomitant use of memantine with cholinesterase inhibition in Alzheimer disease
- (2009) O L Lopez et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Cholinesterase Inhibitor and N-Methyl-D-Aspartic Acid Receptor Antagonist Use in Older Adults with End-Stage Dementia: A Survey of Hospice Medical Directors
- (2009) Joseph W. Shega et al. JOURNAL OF PALLIATIVE MEDICINE
- Cholinesterase Inhibitors and Incidence of Bradycardia in Patients with Dementia in the Veterans Affairs New England Healthcare System
- (2009) Rohini K. Hernandez et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Persistent treatment with cholinesterase inhibitors and/or memantine slows clinical progression of Alzheimer disease
- (2009) Susan D Rountree et al. Alzheimers Research & Therapy
- Cholinesterase Inhibitors and Hospitalization for Bradycardia: A Population-Based Study
- (2009) Laura Y. Park-Wyllie et al. PLOS MEDICINE
- Review: Therapy for Alzheimer's disease: how effective are current treatments?
- (2009) Krista L. Lanctôt et al. Therapeutic Advances in Neurological Disorders
- Long-term Course and Effectiveness of Combination Therapy in Alzheimer Disease
- (2008) Alireza Atri et al. ALZHEIMER DISEASE & ASSOCIATED DISORDERS
- Memantine Treatment in Patients with Mild to Moderate Alzheimers Disease Already Receiving a Cholinesterase Inhibitor: A Randomized, Double-Blind, Placebo-Controlled Trial
- (2008) Anton Porsteinsson et al. Current Alzheimer Research
- Acetylcholinesterase Inhibitor and N-Methyl-D-Aspartic Acid Receptor Antagonist Use among Hospice Enrollees with a Primary Diagnosis of Dementia
- (2008) Douglas J. Weschules et al. JOURNAL OF PALLIATIVE MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now